延长锁骨上岛状皮瓣在修复舌鳞状细胞癌术后缺损中的应用

目的 评价延长锁骨上岛状皮瓣(extended supraclavicular fasciocutaneous island flap,eSIF)修复舌癌术后缺损的可靠性.方法 22例经病理证实的舌癌患者,男17例,女5例,年龄26～73岁,平均(52.9±12.4)岁.应用eSIF修复,皮岛面积(4 cm×6 cm)～(8 cm×14 cm),平均5.5 cm×8.7 cm.结果 20例皮瓣成活率91%(20/22),其中2例皮瓣边缘坏死.舌外形恢复,语音、吞咽功能良好;瘢痕隐蔽,肩功能运动不受影响.随访观察5～16个月,18例生存良好;2例术后半年对侧颈淋巴结转移,经挽救性手术,目前仍存活;2例患者分别于术后8和10个月死于远处转移.结论 eSIF是修复舌癌术后缺损的可靠方法.

Abstract：

Objective To assess the reliability and usefulness of the extended supraclavicular fasciocutaneous island flap (eSIF)for reconstructing soft tissue defects followinng tongue cancer ablation.Methods Twenty-two tongue defects in 22 patients with tongue cancer were repaired with eSIF after resection of the tongue malignant tumours. The sizes of the skin paddle ranged from ( 4 cm× 6 cm ) to (8 cm× 14 cm)( average: 5.5 cm × 8.7 cm). Results The eSIF survived in twenty cases, including two cases with minimal partial necrosis. The patients were follwed up for 5-16 months. Eighteen patients were alive with disease free,two were alive with disease and two died of a lung and liver metastasis. Conclusions The eSIF is reliable for reconstructing oral defects following the ablation of advanced oral malignant tumors.

Reconstruction of tongue defects following oral cancer ablation with extended supraclavicular fasciocutaneous island flap

Objective To assess the reliability and usefulness of the extended supraclavicular fasciocutaneous island flap (eSIF)for reconstructing soft tissue defects followinng tongue cancer ablation.Methods Twenty-two tongue defects in 22 patients with tongue cancer were repaired with eSIF after resection of the tongue malignant tumours. The sizes of the skin paddle ranged from ( 4 cm× 6 cm ) to (8 cm× 14 cm)( average: 5.5 cm × 8.7 cm). Results The eSIF survived in twenty cases, including two cases with minimal partial necrosis. The patients were follwed up for 5-16 months. Eighteen patients were alive with disease free,two were alive with disease and two died of a lung and liver metastasis. Conclusions The eSIF is reliable for reconstructing oral defects following the ablation of advanced oral malignant tumors.